XML 78 R67.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity - Schedule of Stock Option Activity (Detail)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Share-Based Payment Arrangement [Abstract]  
Number of Shares, Outstanding, Beginning Balance | shares 89
Number of Shares, Granted | shares 144
Number of Shares, Exercised | shares (2)
Number of Shares, Forfeited | shares (1)
Number of Shares, Outstanding, Ending Balance | shares 230
Number of Shares, Exercisable at March 31, 2023 | shares 86
Number of Shares, Vested and expected to vest at March 31, 2023 | shares 230
Weighted - Average Exercise Price Per Share, Outstanding, Beginning balance | $ / shares $ 35.58
Weighted - Average Exercise Price Per Share, Granted | $ / shares 33.04
Weighted - Average Exercise Price Per Share, Exercised | $ / shares 34.37
Weighted - Average Exercise Price Per Share, Forfeited | $ / shares 28.04
Weighted - Average Exercise Price Per Share, Outstanding, Ending balance | $ / shares 34.01
Weighted - Average Exercise Price Per Share, Exercisable at March 31, 2023 | $ / shares 35.64
Weighted - Average Exercise Price Per Share, Vested and expected to vest at March 31, 2023 | $ / shares $ 34.01
Weighted - Average Remaining Contractual Term, Outstanding at March 31, 2023 6 years 10 months 24 days
Weighted - Average Remaining Contractual Term, Exercisable at March 31, 2023 1 year 10 months 9 days
Weighted - Average Remaining Contractual Term, Vested and expected to vest at March 31, 2023 6 years 10 months 24 days
Aggregate Intrinsic Value, Outstanding at March 31, 2023 | $ $ 5
Aggregate Intrinsic Value, Exercisable at March 31, 2023 | $ 5
Aggregate Intrinsic Value, Vested and expected to vest at March 31, 2023 | $ $ 5